Merck KGaA secures CRISPR patent in China – Life Sciences Intellectual Property Review
|
Merck KGaA secures CRISPR patent in China
Life Sciences Intellectual Property Review With a 13-year history in the genome-editing field, Merck KGaA has related patent filings for its “insertion CRISPR method” in the US, Brazil, India and Japan. The company also has had similar key patents granted in Australia, Canada, Europe, Israel … |
